Coronavirus Update #48 January 25, 2021
Cumulative number of reported cases: 999,2565 (as of January 25)
Rupiah to US$14,082
Jakarta Stock Exchange Index: 6258
Because of the rise in COVID patients in Jakarta and other urban areas many hospitals are at or near capacity and alternate accommodations are being utilized.
Indonesia reached a 25% positivity rate throughout most of the last week. PCR testing levels have flatlined while daily case detections have jumped levels from 4,000 in November to 12,568 on January 20. The virus continues to reach its tentacles throughout the country and the above statistics may be masking a higher level of incidence.
The government extended social restrictions Jakarta in urban areas through February 8. Private companies with good cold storage, such as ice cream distributor Unilever and pharmaceutical maker Kalbe Farma have been enlisted to use their logistics capabilities to store and ship vaccines to 20,00 health clinics.
Coordinating Minister Hartarto, head of the Committee on COVID 19 told AICC that 30,000 vaccinators are being lined up, each with the mandate to vaccinate 30 people a day. At that rate, and if sufficient supply is available, a substantial proportion of the population will be immunized within 6 months.
A recent COVID outbreak in China could threaten the availability of Indonesia’s main vaccine source, CoronaVac made by Sinovac. Indonesia does have agreements with other suppliers such as AstraZeneca but has not received any allocations yet.
Foreigners are not currently permitted to enter Indonesia without a valid residency permit. The restriction expires February 8 but could be extended.
Visit Indonesian Immigration (https://www.imigrasi.go.id) and the Indonesian Embassy (https://kemlu.go.id/washington/en) for updated visa and entry requirements as regulations may change frequently.
(sources: International and Indonesia news media, Bali Update (from balidiscovery.com), Reformasi Weekly)